The next generation of RNA chips

A full-size, high-density RNA microchip is about the size of a fingernail and can contain up to 780 000 unique RNA sequences, each occupying a ~14 x 14 μm² area. The presence and the quality of the RNA can be verified via the addition of a complementary DNA strand with a green fluorescent tag.
Credit: (c) Tadika Kekić

Research team achieves breakthrough: chemical synthesis of high-density RNA microarrays now faster and more efficient.

An international research team led by the University of Vienna has succeeded in developing a new version of RNA building blocks with higher chemical reactivity and photosensitivity. This can significantly reduce the production time of RNA chips used in biotechnological and medical research. The chemical synthesis of these chips is now twice as fast and seven times more efficient. The results of the research were recently published in the prestigious journal Science Advances.

The emergence and approval of RNA-based medical products, such as mRNA vaccines during the COVID-19 pandemic, has brought the RNA molecule into the public eye. RNA (ribonucleic acid) is an information-carrying polymer – a chemical compound made up of similar subunits – but with far greater structural and functional diversity than DNA. About 40 years ago, a method was developed for the chemical synthesis of DNA and RNA, in which any sequence can be assembled from DNA or RNA building blocks using phosphoramidite chemistry. The assembly of a nucleic acid chain is carried out step by step using these special chemical building blocks (phosphoramidites). Each building block carries chemical ‘protecting groups’ that prevent unwanted reactions and ensure the formation of a natural link in the nucleic acid chain.

Overcoming challenges

This chemical method is also used in the production of microchips (microarrays), where millions of unique sequences can be synthesised and analysed simultaneously on a solid surface the size of a fingernail. While DNA microarrays are already widely used, adapting the technology to RNA microarrays has proved difficult due to the lower stability of RNA.

In 2018, the University of Vienna demonstrated how high-density RNA chips can be produced through photolithography: by precisely positioning a beam of light, areas on the surface can be prepared for the attachment of the next building block through a photochemical reaction. Although this first report was a world first and remains unrivalled, the method suffered from long production times, low yields and poor stability. This approach has now been greatly improved.

Development of a new generation of RNA building blocks

A team from the Institute of Inorganic Chemistry at the University of Vienna, in collaboration with the Max Mousseron Institute for Biomolecules at the University of Montpellier (France), has now developed a new version of RNA building blocks with higher chemical reactivity and photosensitivity. This advance significantly reduces the production time of RNA chips, making synthesis twice as fast and seven times more efficient. The innovative RNA chips can be used to screen millions of candidate RNAs for valuable sequences for a wide range of applications.

“Making RNA microarrays containing functional RNA molecules was simply out of reach with our earlier setup, but it is now a reality with this improved process using the propionyloxymethyl (PrOM) protecting group”, says Jory Lietard, Assistant Professor at the Institute of Inorganic Chemistry.

As a direct application of these improved RNA chips, the publication features a study of RNA aptamers, small oligonucleotides that specifically bind to a target molecule. Two “light-up” aptamers that produce fluorescence upon binding to a dye were chosen and thousands of variants of these aptamers were synthesized on the chip. A single binding experiment is sufficient to obtain data on all variants simultaneously, which opens the way for the identification of improved aptamers with better diagnostic properties.

“High-quality RNA chips could be especially valuable in the rapidly growing field of non-invasive molecular diagnostics. New and improved RNA aptamers are critically sought after, such as those that can track hormone levels in real-time or monitor other biological markers directly from sweat or saliva,” says Tadija Kekić, PhD candidate in the group of Jory Lietard.

This work was financially supported by a joint grant of the Agence Nationale pour la Recherche/Austrian Science Fund (FWF International Program I4923).

Journal: Science Advances
DOI: 10.1126/sciadv.ado6762
Article Title: Accelerated, high quality photolithographic synthesis of RNA microarrays in situ
Article Publication Date: 31-Jul-2024

Media Contact

Alexandra Frey
University of Vienna
presse@univie.ac.at
Office: 01-4277

www.univie.ac.at

Media Contact

Alexandra Frey
University of Vienna

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

Super-precise spectrometer enabled by latent information carried by photons

Two researchers at the University of Warsaw developed a quantum-inspired super-resolving spectrometer for short pulses of light. The device designed in the Quantum Optical Devices Lab at the Centre for…

New method for fingerprint analysis holds great promise

Overlapping and weak fingerprints pose challenges in criminal cases. A new study offers a solution and brings hope for using chemical residues in fingerprints for personal profiling. A groundbreaking study…

Neoself-antigens induce autoimmunity in lupus

Reactivation of Epstein–Barr virus infection increases the production of neoself-antigens, which induce an autoimmune response, in patients with lupus. Autoimmune diseases are widespread and notoriously difficult to treat. In part,…

Partners & Sponsors